C. Nerl

1.2k total citations
24 papers, 368 citations indexed

About

C. Nerl is a scholar working on Immunology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, C. Nerl has authored 24 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 11 papers in Genetics and 7 papers in Pathology and Forensic Medicine. Recurrent topics in C. Nerl's work include Chronic Lymphocytic Leukemia Research (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). C. Nerl is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Immunodeficiency and Autoimmune Disorders (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). C. Nerl collaborates with scholars based in Germany, Austria and United States. C. Nerl's co-authors include Dieter Kabelitz, W. Siegert, K. Lennert, G. Brittinger, Markus Tiemann, D. Huhn, Klaus Pfeffer, Alexander G Agthe, M. Engelhard and Ottmar Janßen and has published in prestigious journals such as The Journal of Experimental Medicine, Blood and The Journal of Immunology.

In The Last Decade

C. Nerl

22 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Nerl Germany 10 174 163 134 107 72 24 368
Auayporn Nademanee United States 8 152 0.9× 75 0.5× 99 0.7× 105 1.0× 151 2.1× 9 340
Marjan Ertault France 9 222 1.3× 51 0.3× 84 0.6× 88 0.8× 63 0.9× 14 306
A. Copplestone United Kingdom 7 239 1.4× 209 1.3× 375 2.8× 59 0.6× 144 2.0× 13 486
P Travade France 7 246 1.4× 230 1.4× 361 2.7× 60 0.6× 78 1.1× 20 439
Shigeyuki Toyoizumi Japan 9 88 0.5× 138 0.8× 162 1.2× 116 1.1× 285 4.0× 20 623
M V Joyner United Kingdom 11 59 0.3× 96 0.6× 161 1.2× 145 1.4× 297 4.1× 24 444
Gianpaolo Marcacci Italy 8 192 1.1× 60 0.4× 129 1.0× 115 1.1× 80 1.1× 17 313
A. G. Bynoe United Kingdom 11 74 0.4× 148 0.9× 108 0.8× 59 0.6× 250 3.5× 23 403
Maria Chiara Tisi Italy 11 150 0.9× 65 0.4× 72 0.5× 142 1.3× 34 0.5× 26 293
W. Sommerfeld Germany 6 115 0.7× 57 0.3× 168 1.3× 143 1.3× 217 3.0× 8 410

Countries citing papers authored by C. Nerl

Since Specialization
Citations

This map shows the geographic impact of C. Nerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Nerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Nerl more than expected).

Fields of papers citing papers by C. Nerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Nerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Nerl. The network helps show where C. Nerl may publish in the future.

Co-authorship network of co-authors of C. Nerl

This figure shows the co-authorship network connecting the top 25 collaborators of C. Nerl. A scholar is included among the top collaborators of C. Nerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Nerl. C. Nerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nerl, C., et al.. (2008). Agranulozytose durch infektiös-toxische Knochenmarkschädigung nach Borrelien-Infektion. DMW - Deutsche Medizinische Wochenschrift. 120(18). 636–640.
2.
Nerl, C., et al.. (2008). Polyangiitis-overlap-Syndrom. DMW - Deutsche Medizinische Wochenschrift. 119(17). 618–623. 2 indexed citations
3.
Schlenk, Richard F., Ulrich Germing, Frank Hartmann, et al.. (2005). High-dose cytarabine and mitoxantrone in consolidation therapy for acute promyelocytic leukemia. Leukemia. 19(6). 978–983. 30 indexed citations
5.
Hallek, Michael, Michael Bergmann, G. Brittinger, et al.. (2002). Chronische lymphatische Leukämie Aktuelle Therapiekonzepte. Der Internist. 43(10). 1245–1254.
6.
Knauf, Wolfgang, Irmgard Langenmayer, Brigitte Mohr, et al.. (1997). Serum Levels of Soluble CD23, but not Soluble CD25, Predict Disease Progression in Early Stage B-Cell Chronic Lymphocytic Leukemia. Leukemia & lymphoma. 27(5-6). 523–532. 29 indexed citations
7.
Siegert, W., C. Nerl, Alexander G Agthe, et al.. (1995). Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: Prognostic impact of clinical observations and laboratory findings at presentation. Annals of Oncology. 6(7). 659–664. 88 indexed citations
8.
Nerl, C., et al.. (1994). Agranulocytosis induced by antithyroid therapy: effects of treatment with granulocyte colony stimulating factor. Journal of Molecular Medicine. 72(5). 390–2. 6 indexed citations
9.
Nüßler, V., R. Pelka‐Fleischer, H. Zwierzina, et al.. (1994). Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes — first experience with their reversal. Annals of Hematology. 69(1). S25–S29. 17 indexed citations
10.
Metzger, Ralf, Georg Melmer, S Schondelmaier, et al.. (1993). Leukaemic T Cells from Patients with Chronic Lymphocytic Leukaemia of T‐Cell Origin Respond to Staphylococcus aureus Enterotoxin Superantigens. Scandinavian Journal of Immunology. 37(2). 245–250. 3 indexed citations
11.
Knauf, Wolfgang, C. Nerl, Hermann Dietzfelbinger, et al.. (1992). lnterferon-alpha2b for Early Phase Chronic Lymphocytic Leukemia with High Risk for Progression – First Results of a Randomized Multicenter AlO-Study. Oncology Research and Treatment. 15(1). 55–57. 1 indexed citations
12.
Duan, Xiaochu, C. Nerl, Ottmar Janßen, & Dieter Kabelitz. (1992). B-cell maturation in chronic lymphocytic leukaemia. IV. T-cell-dependent activation of leukaemic B cells by staphylococcal enterotoxin 'superantigens'.. PubMed. 75(3). 420–6. 3 indexed citations
13.
Röcken, Martin, et al.. (1989). [Lymphocyte subpopulations in patients with skin basalioma of the trunk].. PubMed. 64(3). 212–7. 1 indexed citations
15.
Gastl, Guenther, C. Nerl, W. Aulitzky, et al.. (1989). Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.. PubMed. 3(6). 453–60. 12 indexed citations
16.
Nerl, C., Ottmar Janßen, & Dieter Kabelitz. (1988). B cell maturation in chronic lymphocytic leukemia. III. Effect of recombinant cytokines on leukemic B cell proliferation.. PubMed. 2(12 Suppl). 50S–56S. 7 indexed citations
17.
Pfeffer, Klaus, C. Nerl, & Dieter Kabelitz. (1987). B Cell Maturation in Chronic Lymphocytic Leukemia. Immunobiology. 175(3). 172–182. 13 indexed citations
18.
Emmerich, B., et al.. (1987). Dose-response relationship in the treatment of idiopathic thrombocytopenic purpura with intravenous immunoglobulin. Journal of Molecular Medicine. 65(8). 369–372. 9 indexed citations
19.
Nerl, C., G. Valet, Dolores J. Schendel, & Rudolf Wank. (1982). Early transmembrane potential changes of lymphocytes in mixed lymphocyte cultures as detected by flow-cytometry. Die Naturwissenschaften. 69(6). 292–294. 6 indexed citations
20.
Nerl, C., H. Grosse‐Wilde, & G. Valet. (1978). Association of low C2 and C4 serum levels with the HLA-DW2 allele in healthy individuals.. The Journal of Experimental Medicine. 148(3). 704–713. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026